Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999
A Patient with Primary Biliary Cirrhosis and Multiple Sclerosis
Am J Med 92:433-436, Pontecorvo,M.J.,et al, 1992
Autoimmunity in Multiple Sclerosis
Neurol 38:371-374, DeKeyser,J., 1988
Immunologic Aspects of Neurological & Neuromuscular Diseases
JAMA 258:2970-2973, Zweiman,B.&Arnason,B.G.W., 1987
Multiple Sclerosis & Autoimmune Diseases
Neurol 33:97-98, Lo,R.,et al, 1983
Antibodies to Oligodendroglia in Patient with Multiple Sclerosis
NEJM 297:1207, Abramsky,O.,et al, 1977
Multiple Sclerosis Associated with Defects in Neuromuscular Transmission
JNNP 35:385, Patten,B.M.,et al, 1972
Incidence of Uveitis in Multiple Sclerosis
Am J Ophthalmol 52:540, Riehl,J.L.,et al, 1966